Pages that link to "Q33917008"
Jump to navigation
Jump to search
The following pages link to Type V osteogenesis imperfecta: a new form of brittle bone disease (Q33917008):
Displaying 50 items.
- Bisphosphonate therapy for osteogenesis imperfecta (Q24194821) (← links)
- Bisphosphonate therapy for osteogenesis imperfecta (Q24240782) (← links)
- A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor (Q24336923) (← links)
- Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation (Q24610376) (← links)
- Syndromes with congenital brittle bones (Q24805789) (← links)
- Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation (Q26824200) (← links)
- New genes in bone development: what's new in osteogenesis imperfecta (Q26864752) (← links)
- Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment (Q27025005) (← links)
- Osteopotentia regulates osteoblast maturation, bone formation, and skeletal integrity in mice (Q28593630) (← links)
- CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII (Q33673233) (← links)
- Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta (Q33772970) (← links)
- Osteogenesis imperfecta: a case report and review of literature (Q33852718) (← links)
- Potential implications of cell therapy for osteogenesis imperfecta (Q33863266) (← links)
- Recent advances in osteogenesis imperfecta. (Q34031264) (← links)
- Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen (Q34101398) (← links)
- Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta (Q34114280) (← links)
- Hyperuricemia cosegregating with osteogenesis imperfecta is associated with a mutation in GPATCH8. (Q34186159) (← links)
- A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus (Q34292231) (← links)
- Osteogenesis imperfecta (Q34316613) (← links)
- Osteoporosis in childhood: bone density of children in health and disease (Q34342546) (← links)
- Osteoporosis in children and adolescents: diagnosis, risk factors, and prevention (Q34342552) (← links)
- Bisphosphonate therapy for osteogenesis imperfecta. (Q34543060) (← links)
- The radiographic approach to child abuse (Q34548000) (← links)
- Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta (Q34595345) (← links)
- Case report: osteogenesis imperfecta Elusive cause of fractures. (Q34682446) (← links)
- The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta (Q34815287) (← links)
- Modeling the benefits of pamidronate in children with osteogenesis imperfecta (Q34816036) (← links)
- Phenotype and genotype analysis of Chinese patients with osteogenesis imperfecta type V. (Q34973809) (← links)
- Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year (Q35000729) (← links)
- Genetic evaluation of suspected osteogenesis imperfecta (OI). (Q35033905) (← links)
- Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression. (Q35055113) (← links)
- Phenotypic characterization of skeletal abnormalities of Osteopotentia mutant mice by micro-CT: a descriptive approach with emphasis on reconstruction techniques (Q35074900) (← links)
- A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation (Q35096701) (← links)
- The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V (Q35132933) (← links)
- Gene therapy approaches for osteogenesis imperfecta (Q35629569) (← links)
- Stapes surgery in osteogenesis imperfecta in Finland (Q35724742) (← links)
- Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of Akt (Q35922333) (← links)
- Osteogenesis Imperfecta: A Review with Clinical Examples. (Q35932671) (← links)
- Spondylolisthesis caused by extreme pedicle elongation in osteogenesis imperfecta (Q36144876) (← links)
- A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V. (Q36152886) (← links)
- Unexplained fractures in infancy: looking for fragile bones (Q36154523) (← links)
- Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long? (Q36194937) (← links)
- Osteoporosis in children and adolescents: etiology and management (Q36284471) (← links)
- Clinical and Molecular Characterization of Osteogenesis Imperfecta Type V. (Q36325726) (← links)
- Dentinogenesis imperfecta associated with osteogenesis imperfecta. (Q36377915) (← links)
- Child abuse and osteogenesis imperfecta: how can they be still misdiagnosed? A case report (Q36505635) (← links)
- Osteogenesis imperfecta: new treatment options (Q36648161) (← links)
- Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation (Q36832578) (← links)
- Animal models of osteogenesis imperfecta and related syndromes (Q36861283) (← links)
- Advances in the diagnosis and treatment of osteoporosis (Q36961866) (← links)